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Interview With American Association for
the Study of Liver Diseases President
Dr. Anna Lok
Werecently caught up withAmericanAssocia-tion for the Study of Liver Diseases(AASLD) presidentDr. Anna Lok to discuss
the society’s recent accomplishments and future goals as well
asDr. Lok’s advice for the next generation of hepatologists.
In addition to being AASLD’s current president, Dr.
Lok is director of Clinical Hepatology and the assistant
dean for Clinical Research at the University of Michi-
gan where she sees patients, conducts research, and
mentors three junior faculty members, one gastroenter-
ology Fellow, and a visiting scholar from China. She
recently shared the following thoughts on her experience
as a member and leader of AASLD.
Can you provide some historical perspectives detail-
ing your own involvement with AASLD?
I am honored and humbled to be selected to serve as
president of AASLD—the premier hepatology society
with more than 5,000 members around the world. I
first joined AASLD 30 years ago, and it has been my
professional home since.
Being a member of AASLD has benefited me in
many ways, providing opportunities
 to present my research findings
 to meet other investigators in the field, to learn
from them and to collaborate
 to speak and moderate at postgraduate courses,
meeting sessions/workshops, and single topic
conferences (STCs)
 to serve as associate editor of Hepatology
 to serve on committees and hone my leadership
skills.
AASLD and the field of hepatology have grown
immensely since my first Liver Meeting in 1983.
While we have made much progress, there remain
many liver diseases for which our understanding is lim-
ited and our ability to treat is constrained. As the inci-
dence and prevalence of some liver diseases decrease,
others persist or emerge. Hepatology remains an excit-
ing specialty for young physicians and investigators.
There is no better time to become a hepatologist and a
researcher in liver diseases.
You just chaired your first Governing Board meeting
in March 2017 as the sixty-eighth president of
AASLD. Can you share with the readers of Hepatol-
ogy Communications some of the upcoming opportu-
nities, initiatives, and trends we can expect for the
membership of AASLD?
I am very excited to share with our members a wide
array of new initiatives catered to each of our constitu-
ent groups. Our membership increased from 3,486 in
2012 to 5,433 at last count, with the greatest growth in
trainees and associate members.
Trainees: Five years ago, we launched the Emerging
Liver Scholars Program to attract and cultivate residents
in internal medicine, surgery, pediatrics, and pathology
to hepatology. To date, 147 residents have gone through
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this program and 70% are currently undergoing or have
completed gastroenterology/hepatology training. The
number of applicants has increased from 17 in 2012 to
102 in 2016. AASLD Governing Board just approved a
5-year extension of this program, and we are planning
to increase the funding allocated to this program. We
are also expanding this program to include medical stu-
dents and Ph.D. students.
Trainee members and young investigators: We
started a mentoring program in 2015, matching Fel-
lows of AASLD to trainees and young investigators.
This program was for domestic members only in 2015
and was extended to international members in 2016.
Watch for announcements in June for an opportunity
to be matched to an expert in the field.
The Liver Meeting has always included many pro-
grams, such as the Career Development Workshop
and Clinical Research Symposium, designed for
trainee members and young investigators. In 2015,
academic debates were introduced. Also in 2015, we
started scheduling all these programs on Friday and
designated it as Trainee Day, finishing the day with a
trainee reception to provide a venue for trainees to get
to know each other and to network. In 2016, we pro-
vided space for a young investigators’ lounge to
increase opportunities for networking among peers and
consultation hours with established investigators.
In January 2017, we invited the chair of the Training
and Workforce Committee Gautham Reddy to attend
the Scientific Program Committee meeting to provide
input on planning of The Liver Meeting program. While
there are many programs specifically for trainees at The
Liver Meeting, we will initiate several new programs to
help our trainee members and young investigators acquire
the skills they need to succeed. Many of these new pro-
grams are based on feedback from a young investigator
focus group that was convened at The Liver Meeting
2016. In December 2017, we will for the first time partner
with the European Association for the Study of the Liver
in the Master Class program. This will be held alternately
in Europe and in the United States. The program has
been revised to focus on academic and leadership skills. In
March 2018, we will again partner with the American
Gastroenterological Association in the Academic Skills
Workshop. To enable more hepatology young investi-
gators to benefit from this workshop, AASLD will pro-
vide additional funds to increase the number of travel
awards for hepatology fellows and junior faculty to attend
the workshop and provide additional opportunities for
them to network and seek advice on career development
from experienced hepatology faculty. We will also
introduce Meet-the-Professor breakfast or lunch sessions
at The Liver Meeting and at the Clinical Hepatology
Update (formerly Midyear Course) to provide more
opportunities for trainees and young investigators to inter-
act with experienced hepatologists. In April, I met with
the young investigator focus group through a conference
call to hear from them directly about their needs and ideas
and to share with them our plans.
We will also be conducting a survey to assess the
current status of the hepatology workforce and future
needs as well as compensation later this year.
Trainee membership dues: To attract trainees to
join and to encourage them to stay, membership dues
decreased to $25 per year starting in January 2017, and
at the March 2017 Governing Board meeting, we also
approved a decrease in the membership fee during the
transition period from trainee to full membership,
$125 in year 1 and $250 in year 2.
Medical students, nursing students, and students
studying for an N.P., P.A., or Pharm.D. now have
their own membership category and dues of only $25
per year. This important membership category will
allow us to track a student all the way into residency,
fellowship, and early career and to plan for the future
of hepatology providers.
All the above reflects AASLD’s serious commitment
to the training and success of our next generation.
Associate members: They are one of the fastest
growing constituent groups with diverse affiliations,
including registered nurses, nurse practitioners, physician
assistants, pharmacists, and clinical research coordinators.
We will also reach out to dietitians who play an increas-
ingly important role in hepatology practice, and we will
increase programs on nutrition and liver diseases.
We will be conducting a survey to better understand
our associate members and the needs of each group so
we can design programs that meet their needs.
In January 2017, we invited the chair of the Associ-
ates Committee Patrick Horne to attend the Scientific
Program Committee meeting to provide input on plan-
ning of The Liver Meeting program. Starting in 2018,
two representatives from the Associates Committee will
be involved in planning the program for Clinical Hepa-
tology Updates, allowing them to design programs
catered to the needs of our associate members.
Seasoned members: We will continue to provide
high-quality educational and scientific programs not
only at The Liver Meeting but also throughout the
year. STCs, which provided a venue for like minds to
get together to discuss clinical and research topics of
mutual interest and to network, will be resumed in
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September 2017 and will be held annually going for-
ward. In addition, there will be an Endpoints Confer-
ence, an Emerging Trends Conference, and a Clinical
Hepatology Update each year. Ideas and programs will
originate from special interest groups or committees,
e.g., STC through special interest groups and Clinical
Hepatology through Training and Workforce Com-
mittee/Practice Committee/Associates Committee.
We also added six new committees in 2017 for a total
of 22 committees that provide increased opportunities
for our members to play a leading role in AASLD and
to influence programming.
Maintenance of certification (MOC): For domes-
tic members, American Board of Internal Medicine
requirements for MOC are a major concern. In 2017, we
established a committee dedicated to working with the
American Board of Internal Medicine and sister societies
to decrease the burden on our members and to create
more opportunities to accrue MOC credits through par-
ticipation in AASLD programs. The number of MOC
credits our programs provide increased from 31.5 in
2015 to 95.75 in 2016.
Fellows of AASLD: The Fellows of AASLD pro-
gram to honor our loyal members who have made sig-
nificant contributions to the science and practice of
hepatology will continue. Fellows have the opportunity
to give back through our mentoring program.
Innovation Fund launched in 2016: Two pro-
posals were funded in 2016. AASLD has committed
$250,000 each year for this program. There will be two
cycles each year. Additional funds may be allocated if
there are more meritorious proposals than can be cov-
ered by the current budget.
Quality of care, patient outcomes, and perfor-
mance metrics: These are under increasing scrutiny
and linked to payments. The Governing Board
approved funding of phase 1 of the Cirrhosis Collabora-
tive Project led by Fasiha Kanwal, Michael Volk, Amit
Singal, and Jayant Talwalkar. The goals of this project
are to (1) determine metrics of care for liver diseases, (2)
develop a platform to collect data across hepatology
practice, and (3) provide feedback to improve quality of
care and patient outcomes. The project will initially
focus on patients with cirrhosis, regardless of etiology,
with a plan to include disease-specific data in the future.
AASLD just initiated the Global Outreach and
Engagement program in 2015. What feedback and experi-
ence have come from this program based on the initial 1-
year history and what is the outlook for upcoming years?
The Global Outreach and Engagement Task Force
was established in late 2014 to foster collaborations
with sister societies. In 2017, the Global Outreach and
Engagement Committee was established to continue
this effort. The number of programs (endorsement/
sponsorship) increased from 8 in 2015 to 17 by the
first quarter of 2017. Requests for partnership have
grown to the extent that we need to have a more
streamlined and consistent process to review and
approve these requests. At the March 2017 Governing
Board meeting, we approved the updated endorsement
and sponsorship policies. Going forward, we will have
two cycles for requesting submissions, March 1 and
September 1. There will be a rapid review and notifica-
tion in May and November. In addition to responding
to requests from other societies to collaborate, we will
also proactively initiate collaborative programs with
societies in other countries to promote the practice and
science of hepatology. Stay tuned.
A marquee program of AASLD’s global initiatives
is the Research Methodology Workshop, which was
inaugurated in 2004 in collaboration with the Asian
Pacific Association for the Study of the Liver, to pro-
vide training in basic principles of clinical and transla-
tional research for young investigators through didactic
sessions, case studies, poster presentations, and one-
on-one discussions with experienced faculty. AASLD
also provides funds for travel awards for selected young
investigators. In 2016, this was expanded to the Latin
America Association for the Study of the Liver and in
2017 to the Mexican Association of Hepatology.
You are a leader and an emblematic role model for
mentoring and investing in the careers and guidance of
trainees and junior faculty. How are you bringing this
passion to AASLD?
My message to young investigators is take advantage
of the opportunities that AASLD provides for training
and career development, and network with peers and
experienced hepatologists and researchers. Watch for
announcements, inquire, and reach out. Self-introduce
or ask a colleague to introduce and to connect you with
mentors and collaborators. As a foreign medical gradu-
ate who had no training in the United States, I am
where I am today with help from many AASLD mem-
bers. I took advantage of opportunities to serve our soci-
ety; I gained far more than what I put in. Over the years,
I have invested much time and energy mentoring train-
ees and junior faculty not only in my own institute but
also in other institutes. Many have asked why I spend
time on things that do not benefit me, at least not
directly. My response is I want to help others because
someone helped me in the past. The world is a better
place if we all contribute. Plus, the joys of seeing my
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mentees succeed are immeasurable, and the gratification
of witnessing them add another piece to the puzzle is
beyond description. Reach out for help but also extend a
hand to others; together we can do so much more than
when we work in isolation.
AASLD is and traditionally has been a very inclu-
sive professional society that values diversity. As the
fourth female president of AASLD, what is your mes-
sage to our female colleagues and trainees?
I feel very blessed that AASLD is my professional
home and that AASLD values diversity. I am also
blessed to have three outstanding role models: My
mother, who taught me resilience, grew up in a weal-
thy family with several live-in maids, but within 3
years of marrying my father she was in a situation
where my father was unemployed and had tuberculo-
sis and I (the second child) was about to be born. Pro-
fessor Rosie Young, my professor at the University of
Hong Kong, was the second woman to become dean
of my medical school and the first woman to become
provost of the university. Now in her mid-80s, she is
still seeing patients and serving on the university
council. Dame Sheila Sherlock, my mentor in hepa-
tology, is a trail blazer who played a pivotal role in
establishing hepatology as a specialty and the first
woman to become the chair of medicine in the United
Kingdom.
For young female trainees, my message is believe in
yourself. It does not matter whether others believe you
can succeed or not, you must believe that you can. Set
your goals high but be realistic. Develop a plan for
reaching your goals and persevere. Do not give up eas-
ily when you meet hurdles, but do recognize when to
redirect if the initial plan is clearly not working. Reach
out for help—none of us can do it all—and also extend
a hand to help.
Anna S.F. Lok
Department of Internal Medicine
University of Michigan
Ann Arbor, MI
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